Issue 135: Lecanemab – A silver lining for patients with Alzheimer’s
The HEAD Foundation
December 13, 2022
Alzheimer’s disease, which accounts for 60-70% of dementia cases worldwide, may soon be treatable. The
Alzheimer’s disease, which accounts for 60-70% of dementia cases worldwide, may soon be treatable. The
Leaders and changemakers of today face unique and complex challenges. The HEAD Foundation Digest features insights and opinions from those in the know addressing a wide range of pertinent issues that factor in a society’s development.
Informed opinions can inspire healthy discussions and open up our imagination to new possibilities. Interested in contributing? Write to us at info@headfoundation
Leaders and changemakers of today face unique and complex challenges. The HEAD Foundation Digest features insights and opinions from those in the know addressing a wide range of pertinent issues that factor in a society’s development.
Informed opinions can inspire healthy discussions and open up our imagination to new possibilities. Interested in contributing? Write to us at info@headfoundation